William E. Whitehead
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William E. Whitehead has a total of 461 co-authors. Here are the top co-authors by number of shared publications:
- Olafur S. Palsson
Center for Functional GI & Motility Disorders University of North Carolina‐Chapel Hill Chapel Hill North Carolina USA
45 shared publications Marsha J. Turner
23 shared publications- Steve Heymen
Department of Medicine, Division of Gastroenterology, UNC Center for Functional Gastroenterology and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7080, USA
17 shared publications Olafur S. Palsson
School of Medicine University of North Carolina‐Chapel Hill North Carolina USA
16 shared publications- Douglas A. Drossman
Division of Gastroenterology, University of North Carolina at Chapel Hill and Drossman Gastroenterology, Chapel Hill, NC
13 shared publications - Magnus Simren
Department of Molecular and Clinical Medicine Institute of Medicine University of Gothenburg Gothenburg Sweden
12 shared publications
Latest Publications
- 17 June 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (11) , e70080
Development and Validation of a Bowel Diary for Fecal Incontinence: Comparison With a Questionnaire
Background and Aims: Bowel diaries are used to characterize the severity of fecal incontinence (FI) but have not been adequately validated for this purpose. Our aims were to validate a new bowel diary and to compare the characteristics of FI as assessed with a bowel diary and a validated questionnaire.Methods: In this four‐center prospective study, patients with a history of FI and asymptomatic controls completed a 28‐day bowel diary and validated questionnaires to evaluate bowel habits and FI, quality of life related to FI (FIQoL), and PROMIS scales for anxiety, depression, and self‐efficacy.Results: Among 59 participants with FI and 29 asymptomatic controls, the bowel diary was 97% sensitive and 93% specific for distinguishing between FI participants and controls. Over 28 days, FI participants experienced an average [SD] of 31.1 [50.7] FI episodes, consisting of staining (12.6 [14.9]), some stool (12.5 [20.3]), or a full bowel movement (4.4 [8.5]). Correlations between the questionnaire and diary were statistically significant for frequency (Spearman ρ = 0.5, p < 0.001), amount (ρ = 0.4, p < 0.001), and awareness of FI (ρ = 0.3, p = 0.04). In 71% of participants, there was agreement between the consistency of FI as reported in the questionnaire and the diary. More severe FI was associated with poorer FIQoL (p = 0.002). Anxiety, depression, and self‐efficacy scores did not significantly affect the agreement between the frequency of FI reported in the diary and questionnaire.Conclusion: This bowel diary effectively discriminates between healthy participants and those with FI. There is significant, albeit modest, agreement between the characteristics of FI recorded with a diary and a questionnaire.
- 17 June 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (11) , e70080
Development and Validation of a Bowel Diary for Fecal Incontinence: Comparison With a Questionnaire
Background and Aims: Bowel diaries are used to characterize the severity of fecal incontinence (FI) but have not been adequately validated for this purpose. Our aims were to validate a new bowel diary and to compare the characteristics of FI as assessed with a bowel diary and a validated questionnaire.Methods: In this four‐center prospective study, patients with a history of FI and asymptomatic controls completed a 28‐day bowel diary and validated questionnaires to evaluate bowel habits and FI, quality of life related to FI (FIQoL), and PROMIS scales for anxiety, depression, and self‐efficacy.Results: Among 59 participants with FI and 29 asymptomatic controls, the bowel diary was 97% sensitive and 93% specific for distinguishing between FI participants and controls. Over 28 days, FI participants experienced an average [SD] of 31.1 [50.7] FI episodes, consisting of staining (12.6 [14.9]), some stool (12.5 [20.3]), or a full bowel movement (4.4 [8.5]). Correlations between the questionnaire and diary were statistically significant for frequency (Spearman ρ = 0.5, p < 0.001), amount (ρ = 0.4, p < 0.001), and awareness of FI (ρ = 0.3, p = 0.04). In 71% of participants, there was agreement between the consistency of FI as reported in the questionnaire and the diary. More severe FI was associated with poorer FIQoL (p = 0.002). Anxiety, depression, and self‐efficacy scores did not significantly affect the agreement between the frequency of FI reported in the diary and questionnaire.Conclusion: This bowel diary effectively discriminates between healthy participants and those with FI. There is significant, albeit modest, agreement between the characteristics of FI recorded with a diary and a questionnaire.
- Top Cited PapersOpen Access
- 28 May 2025
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 62 (3) , 330-339
Functional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study
Background: Functional dyspepsia (FD) is one of the most common disorders of gut–brain interaction (DGBI). Varying reported population prevalences probably reflect different definitions and methodological approaches.Aim: To study the prevalence and impact of FD and its subgroups in an internet survey.Methods: A total of 54,127 respondents from 26 countries completed the survey including the Rome IV diagnostic questionnaire, Patient Health Questionnaire‐4 (PHQ‐4), PHQ‐12, PROMIS Global‐10, demographics, and medical history. Respondents reporting a history of relevant organic disease, or fulfilling criteria for self‐induced or cyclic vomiting, or cannabinoid hyperemesis were excluded.Results: Rome IV FD prevalence was 7.2% (range 2.2%–12.3%), significantly higher in women and decreased with age. The most prominent subtype was postprandial distress syndrome (PDS) (66.6%). Rome IV IBS was found in 26.1% of those fulfilling FD criteria. Functional heartburn and chronic nausea and vomiting criteria were fulfilled in, respectively, 9.0% and 7.0%. Fulfilling FD symptom criteria was significantly associated with increased prevalence of anxiety and depression and with lower quality of life and higher healthcare seeking behaviour.Conclusions: Rome IV FD is one of the most prevalent DGBI globally. Across countries, it is associated with female sex, younger age, psychological distress, reduced quality of life, and higher health care utilisation. PDS is the dominant subgroup. Overlapping other DGBI are present in a minority.
- 28 May 2025
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 62 (3) , 330-339
Top Cited PapersOpen AccessFunctional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study
Background: Functional dyspepsia (FD) is one of the most common disorders of gut–brain interaction (DGBI). Varying reported population prevalences probably reflect different definitions and methodological approaches.Aim: To study the prevalence and impact of FD and its subgroups in an internet survey.Methods: A total of 54,127 respondents from 26 countries completed the survey including the Rome IV diagnostic questionnaire, Patient Health Questionnaire‐4 (PHQ‐4), PHQ‐12, PROMIS Global‐10, demographics, and medical history. Respondents reporting a history of relevant organic disease, or fulfilling criteria for self‐induced or cyclic vomiting, or cannabinoid hyperemesis were excluded.Results: Rome IV FD prevalence was 7.2% (range 2.2%–12.3%), significantly higher in women and decreased with age. The most prominent subtype was postprandial distress syndrome (PDS) (66.6%). Rome IV IBS was found in 26.1% of those fulfilling FD criteria. Functional heartburn and chronic nausea and vomiting criteria were fulfilled in, respectively, 9.0% and 7.0%. Fulfilling FD symptom criteria was significantly associated with increased prevalence of anxiety and depression and with lower quality of life and higher healthcare seeking behaviour.Conclusions: Rome IV FD is one of the most prevalent DGBI globally. Across countries, it is associated with female sex, younger age, psychological distress, reduced quality of life, and higher health care utilisation. PDS is the dominant subgroup. Overlapping other DGBI are present in a minority.
- 9 January 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (4) , e15000
Complex and Bidirectional Interplay Between Marital Quality, Catastrophizing, Psychological Dysfunction, and Quality of Life in Married Malay Women With Disorder of Gut–Brain Interactions
Background: Disorders of gut–brain interactions (DGBI) affect more women, and marital quality may have been a factor that explains clinical manifestations of DGBI—however, the mechanism is unclear. This study aimed to elucidate supported relationships between DGBI with marital quality and clinical attributes in married Malay women.Methods: This cross‐sectional study involved married Malay women with functional dyspepsia (FD), irritable bowel syndrome (IBS), and FD‐IBS overlap per Rome IV criteria. Multivariate analysis of variance (MANOVA) and Pearson correlation analysis were performed to determine the association between DGBI, marital quality, and clinical attributes of catastrophizing, psychological dysfunction, and quality of life. Path analysis models were developed, tested, and fitted to elucidate relationships that satisfied significance testing and fit indices (termed supported relationship).Key Results: Of 1130 screened participants, 513 were analyzed. The prevalence of FD, IBS, and FD‐IBS overlap was 33.9% (n = 174), 29.5% (n = 151), and 36.6% (n = 188), respectively. Of 17 variables in MANOVA, significant differences in variables were observed for FD vs. FD‐IBS overlap (10), IBS versus FD (10), and IBS versus FD‐IBS overlap (5). Pearson correlation matrices found significant correlations for 15 of 17 variables. After testing and fitting, the third path model (Model 3) was deemed the final model. Model 3 suggested that relationships between DGBI and marital and clinical attributes were complex and bidirectional. The number of supported relationships were 50, 43, and 39 for FD‐IBS overlap, FD, and IBS, respectively.Conclusions and Inferences: Relationships between DGBI, marital quality, and clinical attributes among married Malay women are complex and bidirectional.
- 9 January 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (4) , e15000
Complex and Bidirectional Interplay Between Marital Quality, Catastrophizing, Psychological Dysfunction, and Quality of Life in Married Malay Women With Disorder of Gut–Brain Interactions
Background: Disorders of gut–brain interactions (DGBI) affect more women, and marital quality may have been a factor that explains clinical manifestations of DGBI—however, the mechanism is unclear. This study aimed to elucidate supported relationships between DGBI with marital quality and clinical attributes in married Malay women.Methods: This cross‐sectional study involved married Malay women with functional dyspepsia (FD), irritable bowel syndrome (IBS), and FD‐IBS overlap per Rome IV criteria. Multivariate analysis of variance (MANOVA) and Pearson correlation analysis were performed to determine the association between DGBI, marital quality, and clinical attributes of catastrophizing, psychological dysfunction, and quality of life. Path analysis models were developed, tested, and fitted to elucidate relationships that satisfied significance testing and fit indices (termed supported relationship).Key Results: Of 1130 screened participants, 513 were analyzed. The prevalence of FD, IBS, and FD‐IBS overlap was 33.9% (n = 174), 29.5% (n = 151), and 36.6% (n = 188), respectively. Of 17 variables in MANOVA, significant differences in variables were observed for FD vs. FD‐IBS overlap (10), IBS versus FD (10), and IBS versus FD‐IBS overlap (5). Pearson correlation matrices found significant correlations for 15 of 17 variables. After testing and fitting, the third path model (Model 3) was deemed the final model. Model 3 suggested that relationships between DGBI and marital and clinical attributes were complex and bidirectional. The number of supported relationships were 50, 43, and 39 for FD‐IBS overlap, FD, and IBS, respectively.Conclusions and Inferences: Relationships between DGBI, marital quality, and clinical attributes among married Malay women are complex and bidirectional.
- Open Access
- 25 October 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (1) , e14948
Biofeedback efficacy for outlet dysfunction constipation: Clinical outcomes and predictors of response by a limited approach
Background: Functional defecation disorders (FDD) are a common etiology of refractory chronic constipation (CC). FDD diagnosis (dyssynergic defecation [DD] and inadequate defecatory propulsion [IDP]), requires diagnostic tests including anorectal manometry (ARM) and balloon expulsion test (BET). Biofeedback (BF) is the treatment of choice for DD. The aims of our study were to evaluate: the outcome of BF in a group of constipated patients with defecatory disorders of any etiology; the efficacy of two simple diagnostic tools in predicting BF outcome in the short‐term.Methods: One hundred and thirty‐one refractory CC patients failing the BET underwent BF therapy. Before BF, all patients underwent the following: ARM. Straining questionnaire. The answers were: “belly muscles”; “anal muscles”; “both”; “Don't know/No answer.” Digital rectal examination augmented by abdominal palpation on straining (augmented‐DRE). The BF therapist was blinded to ARM, straining questionnaire, and augmented‐DRE results.Key Results: Eighty‐one patients responded to BF. Gender, age, and IBS‐C showed no significant impact on BF response. Both DD and IDP responded equally to BF, while the rate of response in patients with isolated structural pelvic floor abnormalities was lower (p < 0.001). The answer “anal muscles” to straining questionnaire showed a strong association with BF response (p < 0.001). A lack in abdominal contraction and in anal relaxation on augmented‐DRE were strongly associated with BF response (p < 0.01). Absence of manual maneuvers to facilitate defecation was associated with BF response (p < 0.001).Conclusions & Inferences: BF is the therapy of choice for refractory constipation due to FDD of any etiology, inducing both clinical and anorectal physiology improvement in the short term. Comorbid IBS‐C did not affect outcome while symptomatic isolated pelvic floor abnormalities appeared refractory to behavior treatment.The straining questionnaire and augmented‐DRE outcomes showed a strong correlation with BF response and can be implemented in clinical practice to improve the management of constipated patients by prompting early referral to BF.
- 25 October 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (1) , e14948
Open AccessBiofeedback efficacy for outlet dysfunction constipation: Clinical outcomes and predictors of response by a limited approach
Background: Functional defecation disorders (FDD) are a common etiology of refractory chronic constipation (CC). FDD diagnosis (dyssynergic defecation [DD] and inadequate defecatory propulsion [IDP]), requires diagnostic tests including anorectal manometry (ARM) and balloon expulsion test (BET). Biofeedback (BF) is the treatment of choice for DD. The aims of our study were to evaluate: the outcome of BF in a group of constipated patients with defecatory disorders of any etiology; the efficacy of two simple diagnostic tools in predicting BF outcome in the short‐term.Methods: One hundred and thirty‐one refractory CC patients failing the BET underwent BF therapy. Before BF, all patients underwent the following: ARM. Straining questionnaire. The answers were: “belly muscles”; “anal muscles”; “both”; “Don't know/No answer.” Digital rectal examination augmented by abdominal palpation on straining (augmented‐DRE). The BF therapist was blinded to ARM, straining questionnaire, and augmented‐DRE results.Key Results: Eighty‐one patients responded to BF. Gender, age, and IBS‐C showed no significant impact on BF response. Both DD and IDP responded equally to BF, while the rate of response in patients with isolated structural pelvic floor abnormalities was lower (p < 0.001). The answer “anal muscles” to straining questionnaire showed a strong association with BF response (p < 0.001). A lack in abdominal contraction and in anal relaxation on augmented‐DRE were strongly associated with BF response (p < 0.01). Absence of manual maneuvers to facilitate defecation was associated with BF response (p < 0.001).Conclusions & Inferences: BF is the therapy of choice for refractory constipation due to FDD of any etiology, inducing both clinical and anorectal physiology improvement in the short term. Comorbid IBS‐C did not affect outcome while symptomatic isolated pelvic floor abnormalities appeared refractory to behavior treatment.The straining questionnaire and augmented‐DRE outcomes showed a strong correlation with BF response and can be implemented in clinical practice to improve the management of constipated patients by prompting early referral to BF.
- 16 September 2024
- Published by Springer Nature in Mindfulness
- Vol. 15 (9) , 2233-2244
Mindfulness Training Has Long-Term Therapeutic Benefits in Women With Irritable Bowel Syndrome
Objectives Mindfulness training (MT) has been shown to have substantial therapeutic effects on irritable bowel syndrome (IBS) symptom severity, health-related quality of life, and psychological symptoms at 3 months following an 8-week group MT intervention. This study reports a secondary analysis to examine the long-term trajectory of change in these IBS symptoms. Methods This study analyzed 6- and 12-month follow-up data collected in a randomized controlled pilot study involving 75 adult women meeting Rome II criteria for IBS assigned to 8 weekly 2-hr sessions plus one half-day intensive of either a group mindfulness training (MT) or a validated IBS support group (SG). Outcome measures included the IBS Symptom Severity Scale (IBS-SSS), the IBS-Quality of Life (IBS-QOL) and Visceral Sensitivity Index (VSI) questionnaires, and the Brief Symptom Inventory-18 psychological distress measure. Measures were mailed to all participants who attended at least one treatment session. Analysis included mixed effects models comparing the trajectory of change over time between groups. Results At 6-month follow-up, MT patients had significantly lower mean IBS-SSS scores compared to SG patients (− 123.79 vs. − 51.82, respectively, p = 0.004). At 12-month follow-up, effects were attenuated, with IBS-SSS scores of − 88.93 (p = 0.001) for MT and − 33.63 (p = 0.158) for SG participants, with a clinically important between-group difference of 61 points (p = 0.107). VSI scores significantly improved at both 6- and 12-month follow-up compared to baseline, for the MT group only. Anxiety and depression significantly improved at 6 months, in the MT group only. Conclusions Beneficial effects of an 8-week MT program tailored for IBS persist for up to 12 months after the training. Preregistration ClinicalTrials.gov identifier: NCT00680693.
- 16 September 2024
- Published by Springer Nature in Mindfulness
- Vol. 15 (9) , 2233-2244
Mindfulness Training Has Long-Term Therapeutic Benefits in Women With Irritable Bowel Syndrome
Objectives Mindfulness training (MT) has been shown to have substantial therapeutic effects on irritable bowel syndrome (IBS) symptom severity, health-related quality of life, and psychological symptoms at 3 months following an 8-week group MT intervention. This study reports a secondary analysis to examine the long-term trajectory of change in these IBS symptoms. Methods This study analyzed 6- and 12-month follow-up data collected in a randomized controlled pilot study involving 75 adult women meeting Rome II criteria for IBS assigned to 8 weekly 2-hr sessions plus one half-day intensive of either a group mindfulness training (MT) or a validated IBS support group (SG). Outcome measures included the IBS Symptom Severity Scale (IBS-SSS), the IBS-Quality of Life (IBS-QOL) and Visceral Sensitivity Index (VSI) questionnaires, and the Brief Symptom Inventory-18 psychological distress measure. Measures were mailed to all participants who attended at least one treatment session. Analysis included mixed effects models comparing the trajectory of change over time between groups. Results At 6-month follow-up, MT patients had significantly lower mean IBS-SSS scores compared to SG patients (− 123.79 vs. − 51.82, respectively, p = 0.004). At 12-month follow-up, effects were attenuated, with IBS-SSS scores of − 88.93 (p = 0.001) for MT and − 33.63 (p = 0.158) for SG participants, with a clinically important between-group difference of 61 points (p = 0.107). VSI scores significantly improved at both 6- and 12-month follow-up compared to baseline, for the MT group only. Anxiety and depression significantly improved at 6 months, in the MT group only. Conclusions Beneficial effects of an 8-week MT program tailored for IBS persist for up to 12 months after the training. Preregistration ClinicalTrials.gov identifier: NCT00680693.
- Open Access
- 5 April 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (6) , e14583
Face‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research
Background and Aims: The Rome Foundation Global Epidemiology Study (RFGES) assessed the prevalence, burden, and associated factors of Disorders of Gut–Brain Interaction (DGBI) in 33 countries around the world. Achieving worldwide sampling necessitated use of two different surveying methods: In‐person household interviews (9 countries) and Internet surveys (26 countries). Two countries, China and Turkey, were surveyed with both methods. This paper examines the differences in the survey results with the two methods, as well as likely reasons for those differences.Methods: The two RFGES survey methods are described in detail, and differences in DGBI findings summarized for household versus Internet surveys globally, and in more detail for China and Turkey. Logistic regression analysis was used to elucidate factors contributing to these differences.Results: Overall, DGBI were only half as prevalent when assessed with household vs Internet surveys. Similar patterns of methodology‐related DGBI differences were seen within both China and Turkey, but prevalence differences between the survey methods were dramatically larger in Turkey. No clear reasons for outcome differences by survey method were identified, although greater relative reduction in bowel and anorectal versus upper gastrointestinal disorders when household versus Internet surveying was used suggests an inhibiting influence of social sensitivity.Conclusions: The findings strongly indicate that besides affecting data quality, manpower needs and data collection time and costs, the choice of survey method is a substantial determinant of symptom reporting and DGBI prevalence outcomes. This has important implications for future DGBI research and epidemiological research more broadly.
- 5 April 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (6) , e14583
Open AccessFace‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research
Background and Aims: The Rome Foundation Global Epidemiology Study (RFGES) assessed the prevalence, burden, and associated factors of Disorders of Gut–Brain Interaction (DGBI) in 33 countries around the world. Achieving worldwide sampling necessitated use of two different surveying methods: In‐person household interviews (9 countries) and Internet surveys (26 countries). Two countries, China and Turkey, were surveyed with both methods. This paper examines the differences in the survey results with the two methods, as well as likely reasons for those differences.Methods: The two RFGES survey methods are described in detail, and differences in DGBI findings summarized for household versus Internet surveys globally, and in more detail for China and Turkey. Logistic regression analysis was used to elucidate factors contributing to these differences.Results: Overall, DGBI were only half as prevalent when assessed with household vs Internet surveys. Similar patterns of methodology‐related DGBI differences were seen within both China and Turkey, but prevalence differences between the survey methods were dramatically larger in Turkey. No clear reasons for outcome differences by survey method were identified, although greater relative reduction in bowel and anorectal versus upper gastrointestinal disorders when household versus Internet surveying was used suggests an inhibiting influence of social sensitivity.Conclusions: The findings strongly indicate that besides affecting data quality, manpower needs and data collection time and costs, the choice of survey method is a substantial determinant of symptom reporting and DGBI prevalence outcomes. This has important implications for future DGBI research and epidemiological research more broadly.
- 24 March 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (6) , e14564
Prevalence and associated factors of disorders of gut‐brain interaction in the United States: Comparison of two nationwide Internet surveys
Background: No comprehensive assessment of disorders of gut‐brain interaction (DGBI) in the United States (US) national population has been published in the past three decades. We aimed to provide an updated picture of DGBI in the United States and associated factors, using data from two national Internet surveys.Methods: Data were analyzed from 1949 people surveyed in 2015, and 2023 people surveyed in 2017 as a part of the Rome Foundation Global Epidemiology Study (RFGES). The surveys had nearly identical methodology and included the Rome IV Diagnostic Questionnaire and questions on demographics, quality of life (QoL), emotional symptoms, and healthcare utilization.Key Results: The prevalence of having any DGBI was 36.0% and 39.9% in the two surveys. Prevalence estimates for the 22 DGBI assessed were broadly comparable between the surveys, as their 95% confidence intervals overlapped for every disorder. Females had DGBI more commonly than males in both surveys (odds ratios 1.66 and 1.52), and people of age 65 and older had lower DGBI prevalence than younger age groups. Having DGBI was associated in both surveys with significant QoL impairment, elevated anxiety, depression and somatization symptoms, and increased doctor visits.Conclusions and Inferences: Approximately 4 out of every 10 US adults have a DGBI; more commonly women and people under the age of 65. DGBI adversely affect QoL and emotional well‐being and increase healthcare needs. The similarity of findings between the two surveys supports the reliability of DGBI prevalence estimates obtained with the Internet survey method used globally in the RFGES.
- 24 March 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (6) , e14564
Prevalence and associated factors of disorders of gut‐brain interaction in the United States: Comparison of two nationwide Internet surveys
Background: No comprehensive assessment of disorders of gut‐brain interaction (DGBI) in the United States (US) national population has been published in the past three decades. We aimed to provide an updated picture of DGBI in the United States and associated factors, using data from two national Internet surveys.Methods: Data were analyzed from 1949 people surveyed in 2015, and 2023 people surveyed in 2017 as a part of the Rome Foundation Global Epidemiology Study (RFGES). The surveys had nearly identical methodology and included the Rome IV Diagnostic Questionnaire and questions on demographics, quality of life (QoL), emotional symptoms, and healthcare utilization.Key Results: The prevalence of having any DGBI was 36.0% and 39.9% in the two surveys. Prevalence estimates for the 22 DGBI assessed were broadly comparable between the surveys, as their 95% confidence intervals overlapped for every disorder. Females had DGBI more commonly than males in both surveys (odds ratios 1.66 and 1.52), and people of age 65 and older had lower DGBI prevalence than younger age groups. Having DGBI was associated in both surveys with significant QoL impairment, elevated anxiety, depression and somatization symptoms, and increased doctor visits.Conclusions and Inferences: Approximately 4 out of every 10 US adults have a DGBI; more commonly women and people under the age of 65. DGBI adversely affect QoL and emotional well‐being and increase healthcare needs. The similarity of findings between the two surveys supports the reliability of DGBI prevalence estimates obtained with the Internet survey method used globally in the RFGES.
- Open Access
- 19 August 2022
- Published by Patient-Centered Outcomes Research Institute
Helping Black Patients Decide on a Treatment for Chronic Heart Failure -- The VIVID Study
- 19 August 2022
- Published by Patient-Centered Outcomes Research Institute
Open AccessHelping Black Patients Decide on a Treatment for Chronic Heart Failure -- The VIVID Study
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1407: FACTOR ANALYSIS CONFIRMS GLOBAL VALIDITY OF ROME IV CRITERIA FOR MAJOR DISORDERS OF GUT-BRAIN INTERACTION (DGBI)
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1407: FACTOR ANALYSIS CONFIRMS GLOBAL VALIDITY OF ROME IV CRITERIA FOR MAJOR DISORDERS OF GUT-BRAIN INTERACTION (DGBI)
- 11 November 2021
- Published by Cambridge University Press (CUP)
- p. 137-151
Myelomeningocele Repair
Anesthesia for Maternal-Fetal Surgery - November 2021
- 11 November 2021
- Published by Cambridge University Press (CUP)
- p. 137-151
Myelomeningocele Repair
Anesthesia for Maternal-Fetal Surgery - November 2021